FORT WORTH, Texas (BP) - "Pass the turkey, please." You can hear the subtle scrape of the fork on the plate to get the last delicious bite of grandmother's dressing with giblet gravy. Can you picture the scene? Aunts, uncles, cousins, siblings, parents and grandparents all gathered around a table crowded with various casseroles, another new sweet potato recipe, cranberry sauce and of course, the majestic bird as the main attraction.
Stories of interest to Arkansas Baptists ...
LIMA, Ohio (BP) - Messengers to the State Convention of Baptists in Ohio passed nine resolutions during their annual meeting.
Two resolutions dealt with recent changes at the North American Mission Board. One primarily affirmed NAMB missionaries serving in Ohio while the other requested that NAMB leadership reconsider decisions that would significantly impact their partnership with Southern Baptists in Ohio.
CLARKDALE, Ga. (BP) - Lex Luger - also known as "The Total Package" and "The Narcissist" - gained worldwide fame as a pro wrestling champion. He stood at 6-feet 4-inches tall, weighed 265 pounds and had a 32-inch waist. His muscles were like polished steel and his perfectly sculptured body added to the wrestling mania that had gripped the nation. He frequently highlighted his muscular physique by posing in front of full-length mirrors before many of his matches. His wrestling persona was designed to thrill his fans. His accomplishments in the ring are legendary.
WASHINGTON (BP) - Only 46 percent of children in the United States will reach age 17 having grown up in a home with biological parents who are married -- a figure that has a significant impact on the nation's graduation, poverty and teenage birth rates, according to a new report.
LOS ANGELES (BP) - In a surprising move, the company that launched the nation's first government-approved embryonic stem cell trial is halting further research due to funding - a shift that pro-life leaders say confirms long-held doubts about the value of embryonic stem cells.
Geron, which launched the first FDA-approved embryonic stem cell trial in 2010 with much fanfare, said Nov. 14 it will stop funding its stem cell trials and move that money to cancer research, a move it said is necessary in the "current environment of capital scarcity and uncertain economic conditions."